サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654401

牛乳房炎の市場規模、シェア、動向分析レポート：製品別、投与経路別、治療法別、タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

Bovine Mastitis Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Diagnostics), By Route Of Administration (Intra-Mammary, Systemic), By Therapy, By Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
牛乳房炎の市場規模、シェア、動向分析レポート：製品別、投与経路別、治療法別、タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年01月28日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

牛乳房炎市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の牛乳房炎市場規模は2030年までに26億6,000万米ドルに達する見込みです。

同市場は2025～2030年にかけてCAGR 8.26％で成長すると予測されています。同市場は、牛乳房炎の有病率の増加、乳製品需要の増加、予防対策の採用拡大など、様々な要因によって牽引されています。乳房炎は乳牛によく見られる感染症で、乳量と乳質に大きな影響を与えます。この病気とその経済的影響に対する認識の高まりが、効果的な診断と治療に対する需要を促進しています。

診断の技術的進歩も市場成長を促進する要因の一つです。例えば、Journal of Veterinary Diagnostic Investigation誌によると、牛の乳房炎は酪農業従事者にとって経済的な苦難であり、予防管理戦略はあらゆる酪農事業の長期的な存続に不可欠です。トランスクリプトームやプロテオーム研究、ハンドヘルド機器のナノ・マイクロ製造など、最近の技術の進歩は、乳房炎細菌や炎症バイオマーカーを検出する有望で高感度な方法を提供しています。農場の規模が大きくなるにつれ、革新的で迅速かつ正確な診断技術の必要性が高まっています。マイクロアレイ技術は、6時間で乳房炎を引き起こす病原体の7つの一般的な種を同定でき、感度は94.1%、特異度は100%と報告されており、牛の乳房炎病原体を同定するための遺伝子型アプローチのもう一つの技術的進歩です。

酪農関連製品の需要の増加は、市場の成長強化に役立っています。OECDの2020～2029年までの推定によると、世界の牛乳生産量のほぼ80％は牛乳に由来します。2029年までには、中国とインドが世界の牛乳生産量の30％以上を占めるようになると予想されています。さらにOECDのプロジェクトによると、2022～2031年の間に、牛乳、生鮮乳製品、バター、チーズの世界消費量は増加します。例えば、チーズの消費量は2022年の2万5,500トン/重量から2031年には2万8,136トン/重量に増加すると予測されています。インド報道情報局が2024年5月に発表した数字によると、インドの生乳生産量は2018～2019年の1億8,730万トンから2022～2023年には2億3,058万トンと、CAGR6％以上の伸びを示しました。したがって、これらの要因が市場の成長を促進しています。

牛乳房炎市場レポートハイライト

  • 製品別では、医薬品セグメントが2024年の市場を独占しました。診断セグメントは、診断技術の進歩により、予測期間中に最も速いCAGRで成長すると予測されます。
  • タイプ別では、臨床性乳腺炎が2024年に最大の市場シェアを占め、亜臨床性乳腺炎が予測期間中に最も速いCAGRで成長すると予測されます。
  • 治療法別では、乾乳期が2024年に最大の市場シェアを占めました。
  • 投与経路では、乳房内セグメントが2024年に市場を独占しました。
  • 最終用途別では、動物病院/クリニックが乳房感染症の診断、治療、予防に重要な関与をしているため、2024年には動物病院/クリニックセグメントが最大の売上シェアを占めました。
  • 北米は2024年の世界市場を独占しました。この地域の市場成長を促進する要因には、畜牛人口の増加と、サステイナブル動物性タンパク質源に対する消費者の需要を満たしたいという欲求の高まりがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 牛乳房炎市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析
    • 規制の枠組み
    • 主要国別主要種による推定牛頭数（2024年）
    • 価格分析
    • COVID-19の影響分析

第4章 牛乳房炎市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • 医薬
  • 診断

第5章 牛乳房炎市場：タイプビジネス分析

  • タイプ市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018～2030年
  • 臨床
  • 非臨床

第6章 牛乳房炎市場：治療法ビジネス分析

  • 治療法市場シェア、2024年と2030年
  • 治療法セグメントダッシュボード
  • 市場規模と予測と動向分析、治療法別、2018～2030年
  • 乾燥期
  • 授乳期

第7章 牛乳房炎市場：投与経路ビジネス分析

  • 投与経路市場シェア、2024年と2030年
  • 投与経路セグメントダッシュボード
  • 市場規模と予測と動向分析、投与経路別、2018～2030年
  • 乳房内
  • 全身的

第8章 牛乳房炎市場：最終用途ビジネス分析

  • 最終用途市場シェア、2024年と2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測と動向分析、最終用途別、2018～2030年
  • 動物病院/クリニック
  • その他

第9章 牛乳房炎市場：製品、タイプ、治療法、最終用途、最終用途による地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Boehringer Ingelheim Animal Health
    • Zoetis
    • Ceva
    • Merck &Co., Inc.
    • Elanco
    • Immucell Corporation
    • Virbac.
    • Forte Healthcare Ltd
    • HIPRA
    • Heilsaa

第11章 主要ポイント

図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. Global Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 5. Global Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 6. Global Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 7. Global Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8. Global Bovine Mastitis Market, By Region, 2018 - 2030 (USD Million)
  • Table 9. North America Bovine Mastitis Market, By Country, 2018 - 2030 (USD Million)
  • Table 10. North America Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 11. North America Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 12. North America Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 13. North America Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14. North America Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15. U.S. Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. U.S. Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 18. U.S. Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 19. U.S. Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Canada Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 21. Canada Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 22. Canada Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 23. Canada Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24. Canada Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25. Mexico Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Mexico Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 27. Mexico Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 28. Mexico Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29. Mexico Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Europe Bovine Mastitis Market, By Country, 2018 - 2030 (USD Million)
  • Table 31. Europe Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Europe Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 33. Europe Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 34. Europe Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 35. Europe Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36. Germany Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Germany Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. Germany Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 39. Germany Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 40. Germany Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. UK Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 42. UK Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 43. UK Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 44. UK Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45. UK Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46. France Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 47. France Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 48. France Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 49. France Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 50. France Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51. Italy Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 52. Italy Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 53. Italy Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 54. Italy Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55. Italy Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. Spain Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 57. Spain Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. Spain Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 59. Spain Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 60. Spain Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Denmark Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 62. Denmark Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 63. Denmark Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 64. Denmark Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 65. Denmark Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66. Sweden Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 67. Sweden Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 68. Sweden Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 69. Sweden Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70. Sweden Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71. Norway Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 72. Norway Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 73. Norway Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 74. Norway Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75. Norway Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific Bovine Mastitis Market, By Country, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 78. Asia Pacific Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 79. Asia Pacific Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 80. Asia Pacific Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 81. Asia Pacific Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82. China Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 83. China Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 84. China Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 85. China Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86. China Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87. Japan Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 88. Japan Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 89. Japan Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 90. Japan Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91. Japan Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92. India Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 93. India Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 94. India Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 95. India Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96. India Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 97. South Korea Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 98. South Korea Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 99. South Korea Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 100. South Korea Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 101. South Korea Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 102. Australia Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 103. Australia Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 104. Australia Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 105. Australia Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 106. Australia Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107. Thailand Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 108. Thailand Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 109. Thailand Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 110. Thailand Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 111. Thailand Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 112. Latin America Bovine Mastitis Market, By Country, 2018 - 2030 (USD Million)
  • Table 113. Latin America Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 114. Latin America Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 115. Latin America Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 116. Latin America Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117. Latin America Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 118. Brazil Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 119. Brazil Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 120. Brazil Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 121. Brazil Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 122. Brazil Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 123. Argentina Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 124. Argentina Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 125. Argentina Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 126. Argentina Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 127. Argentina Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 128. Middle East & Africa Bovine Mastitis Market, By Country, 2018 - 2030 (USD Million)
  • Table 129. Middle East & Africa Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 130. Middle East & Africa Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 131. Middle East & Africa Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 132. Middle East & Africa Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 133. Middle East & Africa Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 134. South Africa Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 135. South Africa Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 136. South Africa Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 137. South Africa Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 138. South Africa Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 139. Saudi Arabia Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 140. Saudi Arabia Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 141. Saudi Arabia Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 142. Saudi Arabia Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 143. Saudi Arabia Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 144. UAE Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 145. UAE Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 146. UAE Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 147. UAE Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 148. UAE Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)
  • Table 149. Kuwait Bovine Mastitis Market, By Product, 2018 - 2030 (USD Million)
  • Table 150. Kuwait Bovine Mastitis Market, By Type, 2018 - 2030 (USD Million)
  • Table 151. Kuwait Bovine Mastitis Market, By Therapy, 2018 - 2030 (USD Million)
  • Table 152. Kuwait Bovine Mastitis Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 153. Kuwait Bovine Mastitis Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Bovine Mastitis Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Bovine Mastitis Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Bovine Mastitis Market, for Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 16 Global Bovine Mastitis Market, for Antibiotics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Bovine Mastitis Market, for Vaccines, 2018 - 2030 (USD Million)
  • Fig. 18 Global Bovine Mastitis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Bovine Mastitis Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 20 Global Bovine Mastitis Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 21 Global Bovine Mastitis Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 22 Global Bovine Mastitis Market, for Sub-Clinical, 2018 - 2030 (USD Million)
  • Fig. 23 Global Bovine Mastitis Market, for Therapy, 2018 - 2030 (USD Million)
  • Fig. 24 Global Bovine Mastitis Market, for Dry Period, 2018 - 2030 (USD Million)
  • Fig. 25 Global Bovine Mastitis Market, for Lactating Period, 2018 - 2030 (USD Million)
  • Fig. 26 Global Bovine Mastitis Market, for Route of administration, 2018 - 2030 (USD Million)
  • Fig. 27 Global Bovine Mastitis Market, for Intra-mammary, 2018 - 2030 (USD Million)
  • Fig. 28 Global Bovine Mastitis Market, for Systemic, 2018 - 2030 (USD Million)
  • Fig. 29 Global Bovine Mastitis Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 30 Global Bovine Mastitis Market, for Veterinary Hospitals/Clinics, 2018 - 2030 (USD Million)
  • Fig. 31 Global Bovine Mastitis Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Outlook, 2024 & 2030
  • Fig. 33 North America Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 34 US Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 48 China Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 49 India Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait Bovine Mastitis Market, 2018 - 2030 (USD Million)
  • Fig. 61 Company categorization
  • Fig. 62 Company market position analysis
  • Fig. 63 Strategic framework
目次
Product Code: GVR-4-68040-507-9

Bovine Mastitis Market Growth & Trends:

The global bovine mastitis market size is expected to reach USD 2.66 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.26% from 2025 to 2030. The market is driven by various factors, such as the increasing prevalence of bovine mastitis, rising demand for dairy products, and growing adoption of preventive measures. Mastitis is a common infection among dairy cows, significantly affecting milk yield and quality. The growing awareness of this disease and its economic implications is driving the demand for effective diagnostics and treatments.

Technological advancements in diagnosis are another factor fueling market growth. For example, according to the Journal of Veterinary Diagnostic Investigation, bovine mastitis is an economic hardship for dairy producers, and preventive management strategies are critical to the long-term viability of any dairy business. Recent advances in technology, including transcriptome and proteome studies, as well as nano- and micro-manufacturing of handheld devices, provide promising, sensitive ways for detecting mastitis bacteria and inflammation biomarkers. As farms grow in size, there is an increasing need for innovative, quick, and accurate diagnostic techniques. The microarray technology, which can identify seven prevalent species of mastitis-causing pathogens in 6 hours with a reported sensitivity of 94.1% and specificity of 100%, is another technological advancement of genotypic approaches for the identification of bovine mastitis pathogens.

Increasing demand for dairy related products helps in strengthening the market growth. According to OECD estimations from 2020 to 2029, almost 80% of the world's milk production comes from cow milk. By 2029, it is anticipated that China and India will account for over 30% of the world's milk production. In addition, according to the OECD projects, between 2022 and 2031, global consumption of milk, fresh dairy products, butter, and cheese would rise. For example, it is anticipated that cheese consumption will increase from 25,500 kt pw in 2022 to 28,136 kt pw in 2031. According to figures released by the Press Information Bureau of India in May 2024, milk production in India grew at a CAGR of more than 6%, from 187.30 million tons in 2018 - 2019 to 230.58 million tons in 2022 - 2023. Hence, these factors are propelling market growth.

Bovine Mastitis Market Report Highlights:

  • Based on product, the pharmaceutical segment dominated the market in 2024. While the diagnostics segment is anticipated to grow at the fastest CAGR over the forecast period due to technological advancements in diagnosis.
  • In terms of type, clinical mastitis held the largest market share in 2024, and sub-clinical mastitis is expected to grow at the fastest CAGR over the forecast period.
  • Based on therapy, the dry period segment held the largest market share in 2024.
  • In terms of route of administration, the intra-mammary segment dominated the market in 2024 because it effectively targets the infection inside the udder.
  • Based on end use, the veterinary hospitals/clinics segment accounted for the largest revenue share in 2024 due to their critical involvement in the diagnosis, treatment, and prevention of udder infection.
  • North America dominated the global market in the year 2024. The factors driving the regional market growth include the rising cattle population and the increasing desire to satisfy consumer demands for sustainable animal protein sources.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Therapy
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Bovine Mastitis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of bovine mastitis
      • 3.2.1.2. Technological advancements in diagnosis
      • 3.2.1.3. Rising demand of dairy products
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Increase in antibiotic resistance
  • 3.3. Market Opportunity Analysis
  • 3.4. Market Challenge Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Regulatory Framework
    • 3.5.4. Estimated Cattle Population, by Key Species, Key Country (2024)
    • 3.5.5. Pricing Analysis
    • 3.5.6. COVID-19 Impact Analysis

Chapter 4. Bovine Mastitis Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Pharmaceuticals
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Antibiotics
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Vaccines
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Diagnostics
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Bovine Mastitis Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Clinical
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Sub-Clinical
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Bovine Mastitis Market: Therapy Business Analysis

  • 6.1. Therapy Market Share, 2024 & 2030
  • 6.2. Therapy Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 6.4. Dry Period
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Lactating Period
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Bovine Mastitis Market: Route of Administration Business Analysis

  • 7.1. Route of Administration Market Share, 2024 & 2030
  • 7.2. Route of Administration Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 7.4. Intra-Mammary
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Systemic
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Bovine Mastitis Market: End Use Business Analysis

  • 8.1. End Use Market Share, 2024 & 2030
  • 8.2. End Use Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Veterinary Hospitals/Clinics
    • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Bovine Mastitis Market: Regional Estimates & Trend Analysis by Product, Type, Therapy, End Use, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. U.S. Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Canada Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Mexico Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. UK Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Germany Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. France Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Italy Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Spain Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Norway Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Denmark Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Sweden
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Sweden Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Japan Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. China Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. India Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. South Korea Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Australia
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Australia Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Thailand Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Brazil Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Argentina Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. South Africa Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Saudi Arabia Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. UAE Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Kuwait Bovine Mastitis market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Boehringer Ingelheim Animal Health
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial performance
      • 10.5.1.3. Product benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. Zoetis
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Product benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Ceva
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Product benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. Merck & Co., Inc.
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Product benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. Elanco
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Product benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Immucell Corporation
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Product benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Virbac.
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. Forte Healthcare Ltd
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Product benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. HIPRA
      • 10.5.9.1. Overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Product benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. Heilsaa
      • 10.5.10.1. Overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Product benchmarking
      • 10.5.10.4. Strategic initiatives

Chapter 11. Key Takeaways